BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 19625223)

  • 41. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids.
    Robles-Diaz M; Gonzalez-Jimenez A; Medina-Caliz I; Stephens C; García-Cortes M; García-Muñoz B; Ortega-Alonso A; Blanco-Reina E; Gonzalez-Grande R; Jimenez-Perez M; Rendón P; Navarro JM; Gines P; Prieto M; Garcia-Eliz M; Bessone F; Brahm JR; Paraná R; Lucena MI; Andrade RJ; ;
    Aliment Pharmacol Ther; 2015 Jan; 41(1):116-25. PubMed ID: 25394890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
    Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.
    Devarbhavi H; Dierkhising R; Kremers WK; Sandeep MS; Karanth D; Adarsh CK
    Am J Gastroenterol; 2010 Nov; 105(11):2396-404. PubMed ID: 20648003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
    Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
    Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute liver failure due to a treatment by nimesulide].
    Altwegg R
    Ann Fr Anesth Reanim; 2009 Mar; 28(3):262-3. PubMed ID: 19195818
    [No Abstract]   [Full Text] [Related]  

  • 46. Nimesulide-induced hepatotoxicity and fatal hepatic failure.
    Bissoli F
    Singapore Med J; 2008 May; 49(5):436-7; author reply 438. PubMed ID: 18465058
    [No Abstract]   [Full Text] [Related]  

  • 47. Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes.
    Hou FQ; Zeng Z; Wang GQ
    Cell Biochem Biophys; 2012 Nov; 64(2):77-83. PubMed ID: 22806342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug-induced liver injury in children.
    Amin MD; Harpavat S; Leung DH
    Curr Opin Pediatr; 2015 Oct; 27(5):625-33. PubMed ID: 26208237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review article: drug-induced liver injury in clinical practice.
    Björnsson E
    Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bleeding gastric ulcers and acute hepatitis: 2 simultaneous adverse reactions due to nimesulide in a case].
    Tejos S; Torrejón N; Reyes H; Meneses M
    Rev Med Chil; 2000 Dec; 128(12):1349-53. PubMed ID: 11227244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
    Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-induced liver injury due to antimicrobials, central nervous system agents, and nonsteroidal anti-inflammatory drugs.
    Devarbhavi H; Andrade RJ
    Semin Liver Dis; 2014 May; 34(2):145-61. PubMed ID: 24879980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort.
    Licata A; Minissale MG; Calvaruso V; Craxì A
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):112-121. PubMed ID: 28379588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.
    Lucena MI; Andrade RJ; Kaplowitz N; García-Cortes M; Fernández MC; Romero-Gomez M; Bruguera M; Hallal H; Robles-Diaz M; Rodriguez-González JF; Navarro JM; Salmeron J; Martinez-Odriozola P; Pérez-Alvarez R; Borraz Y; Hidalgo R;
    Hepatology; 2009 Jun; 49(6):2001-9. PubMed ID: 19475693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
    Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
    Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug safety issues of nimesulide in China--nimesulide-induced liver injury.
    Wang Y; Zeng Y; Xu F
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):778-9. PubMed ID: 21714032
    [No Abstract]   [Full Text] [Related]  

  • 58. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Severe acute hepatitis probably induced by nimesulide].
    Rodrigues de Oliveira J; Correia J; Silvestre F; Meirelles A; Bernardo A
    Gastroenterol Clin Biol; 2000 May; 24(5):592-3. PubMed ID: 10891757
    [No Abstract]   [Full Text] [Related]  

  • 60. Nimesulide-induced hepatitis and acute liver failure.
    Weiss P
    Isr Med Assoc J; 1999 Nov; 1(3):221. PubMed ID: 10731347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.